Open Recalls

Recalled product should not be sent directly to American Health Packaging. It should be sent to the third party recall provider described when following directions in the recall notification. Thank you for your assistance and cooperation.

June 2020

Nabumetone Tablets, USP 500 mg

  • Carton NDC: 60687-374-01; Blister NDC: 60687-374-11

May 2020

Doxycycline Hyclate Tablets, USP 100 mg

  • Carton NDC: 62584-693-21; Blister NDC: 62584-693-11

February 2020

Desmopressin Acetate Tablets 0.1 mg, 0.2 mg 

  • 0.1 MG: Carton NDC: 68084-606-21; Blister NDC: 68084-606-11
  • 0.2 MG: Carton NDC: 68084-604-21; Blister NDC: 68084-604-11

December 2019

Raloxifene Hydrochloride Tablets, USP 60 mg

  • Carton NDC: 60687-266-21; Blister NDC: 60687-266-11

November 2019

Ranitidine Tablets, USP 150 mg

  • Carton NDC: 60687-322-01; Blister NDC: 60687-322-11
  • Note: AHP does not have access to supply of manufactured tablets or oral liquid product at this time, but is actively inquiring about availability from all current and future manufacturers. Unfortunately, it may be many months before the manufacturing industry can make Ranitidine products available.

Ranitidine Syrup (Ranitidine Oral Solution USP) 150 mg/10 mL

  • Case NDC: 60687-260-23; Tray NDC: 60687-260-48; Cup NDC: 60687-260-42 
  • Note: AHP does not have access to supply of manufactured tablets or oral liquid product at this time, but is actively inquiring about availability from all current and future manufacturers. Unfortunately, it may be many months before the manufacturing industry can make Ranitidine products available.
  • Case NDC: 60687-260-69; Tray NDC: 60687-260-48; Cup NDC: 60687-260-42

August 2019

Lamivudine Tablets USP 150 mg - Labeling Correction 

  • Carton NDC: 60687-362-21; Blister NDC: 60687-362-11

Carbamazepine Extended Release Tablets, USP, 400 mg

  • Carton NDC: 68084-562-21; Blister NDC: 68084-562-11
Drug Distributor

American Health Packaging distribution facility has been awarded NABP accreditation.

Learn more